The DOI matches its Crossref record; 157 of the 158 references it cites were found in a registry or an index; none of the 175 sources its claims cite is checked for support yet.
Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre- and postconditioning
Open accessAbstract
The production of reactive oxygen species by the mitochondrial complex II (succinate:ubiquinone oxidoreductase) recently has gained broad scientific interest. Depending on the (patho)physiological situation, ROS produced or triggered by complex II can have either beneficial or deleterious effects. This ambivalence can be explained mechanistically by the diverse role of complex II on mitochondrial ROS production: it can be a source as well as a suppressor or enhancer of ROS generation by other respiratory chain complexes. Since complex II directly links the respiratory chain to the tricarboxylic acid (TCA) cycle, the TCA-cycle intermediates - especially oxaloacetate that acts as a high affinity endogenous inhibitor - have major impact on complex II-related ROS release. The review relates the diverse effects of complex II activity on the mitochondrial ROS production that have been observed during cardioprotective ischemic or pharmacological preconditioning and the oxidative burst that occurs during ischemia/reperfusion. This article is part of a Special Issue entitled: Respiratory complex II: Role in cellular physiology and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 175 cited sources checked · 0 supported · 0 flagged
In the paper
“that a drop in ΔΨ by only 5% reduces the hydrogen peroxide release of isolated mitochondria by 95%.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.2. Complex II as a modulator of the ROS production by complexes I and III
What the sources say
- Not checked yetcites [18] 18. T.V. Votyakova, I.J. Reynolds, ΔΨ-dependent and -independent production of re- active oxygen species by rat brain mitochondria, J. Neurochem. 79 (2001) 266-277. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“However, experimental evidence for an oxaloacetate-dependent inhibition of complex II under anoxic conditions is lacking [109].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.2. Complex II as a modulator of the ROS production by complexes I and III
What the sources say
- Not checked yetcites [109] 109. E. Maklashina, A.B. Kotlyar, J.S. Karliner, G. Cecchini, Effect of oxygen on activa- tion state of complex I and lack of oxaloacetate inhibition of complex II in Langendorff perfused rat heart, FEBS Lett. 556 (2004) 64-68. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“We could show in investigations with isolated rat heart mitochondria, that the succinate-driven superoxide production at complex I by RET can be abolished completely by atpenin A5 concentrations of 10 nM, a concentration that only partially inhibited succinate-dependent respiration [16].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.3. Is a mitochondrial K ATP channel involved in cardioprotective preconditioning?
What the sources say
- Not checked yetcites [16] 16. S. Dröse, L. Bleier, U. Brandt, A common mechanism links differently acting com- plex II inhibitors to cardioprotection: modulation of mitochondrial reactive ox- ygen species production, Mol. Pharmacol. 79 (2011) 814-822. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“However, it has to be pointed out that a physiological correlate of the experimentally induced antimycin A inhibition has not been identified yet [25].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.2. Ambivalent roles of complex II and ROS in cardioprotective preconditioning and I/R injury
What the sources say
- Not checked yetcites [25] 25. L. Bleier, S. Dröse, Superoxide generation by complex III: from mechanistic rationales to functional consequences, Biochim. Biophys, Acta (2013), http://dx.doi.org/10. 1016/j.bbabio.2012.12.002. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Furthermore, it is well known that complex II activity can have major impact on the ROS production by complexes I and III [15,16].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 1. Introduction
What the sources say
- Not checked yetcites [15] 15. S. Dröse, P.J. Hanley, U. Brandt, Ambivalent effects of diazoxide on mitochondrial ROS production at respiratory chain complexes I and III, Biochim. Biophys. Acta 1790 (2009) 558-565. source
- Not checked yetcites [16] 16. S. Dröse, L. Bleier, U. Brandt, A common mechanism links differently acting com- plex II inhibitors to cardioprotection: modulation of mitochondrial reactive ox- ygen species production, Mol. Pharmacol. 79 (2011) 814-822. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Under these conditions inhibition of complex II leads to a reduction of complex I related ROS generation [15,16,19,20,24].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 1. Introduction
What the sources say
- Not checked yetcites [15] 15. S. Dröse, P.J. Hanley, U. Brandt, Ambivalent effects of diazoxide on mitochondrial ROS production at respiratory chain complexes I and III, Biochim. Biophys. Acta 1790 (2009) 558-565. source
- Not checked yetcites [16] 16. S. Dröse, L. Bleier, U. Brandt, A common mechanism links differently acting com- plex II inhibitors to cardioprotection: modulation of mitochondrial reactive ox- ygen species production, Mol. Pharmacol. 79 (2011) 814-822. source
- Not checked yetcites [19] 19. Y. Liu, G. Fiskum, D. Schubert, Generation of reactive oxygen species by the mi- tochondrial electron transport chain, J. Neurochem. 80 (2002) 780-787. source
- Not checked yetcites [20] 20. A.J. Lambert, M.D. Brand, Superoxide production by NADH:ubiquinone oxidore- ductase (complex I) depends on the pH gradient across the mitochondrial inner membrane, Biochem. J. 382 (2004) 511-517. source
- Not checked yetcites [24] 24. J.R. Treberg, C.L. Quinlan, M.D. Brand, Evidence for two sites of superoxide produc- tion by mitochondrial NADH-ubiquinone oxidoreductase (complex I), J. Biol. Chem. 286 (2011) 27103-27110. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“On the other hand, inhibition of complex II can increase the generation of superoxide at the ubiquinol oxidation site (Q o site) of complex III under specific conditions [25], i.e. when succinate is the predominant substrate and when the electron transfer between heme b L (low potential heme) and heme b H (high potential heme) is slowed down additionally, e.g. when the ubiquinone reduction site of”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 1. Introduction
What the sources say
- Not checked yetcites [25] 25. L. Bleier, S. Dröse, Superoxide generation by complex III: from mechanistic rationales to functional consequences, Biochim. Biophys, Acta (2013), http://dx.doi.org/10. 1016/j.bbabio.2012.12.002. source
- Not checked yetcites [15,16,[26][27][28][29][30][31]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“It has been observed that loss of function of complex II can lead to the accumulation of succinate and increased ROS generation in mammalian cells (overview in [14,36]).”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [14] 14. T.M. Iverson, E. Maklashina, G. Cecchini, Structural basis for malfunction in com- plex II, J. Biol. Chem. 287 (2012) 35430-35438. source
- Not checked yetcites [36] 36. S.J. Ralph, R. Moreno-Sanchez, J. Neuzil, S. Rodriguez-Enriquez, Inhibitors of suc- cinate: quinone reductase/complex II regulate production of mitochondrial re- active oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death, Pharm. Res. 28 (2011) 2695-2730. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Ishii and coworkers observed that a mutation in the SdhC subunit in transgenic mouse fibroblasts and conditional transgenic mice induces mitochondrial respiratory chain dysfunction and increased ROS production [95].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [95] 95. T. Ishii, M. Miyazawa, A. Onodera, K. Yasuda, N. Kawabe, M. Kirinashizawa, S. Yoshimura, N. Maruyama, P.S. Hartman, N. Ishii, Mitochondrial reactive oxygen species generation by the SDHC V69E mutation causes low birth weight and neonatal growth retardation, Mitochondrion 11 (2011) 155-165. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“A significant contribution of complexes I and III to the detected ROS generation could be excluded by the addition of rotenone (that inhibits ROS production by RET at complex I) and myxothiazol (that inhibits ROS production at the Q o site of complex III and at the same time served as the downstream block).”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [37] 37. C.L. Quinlan, A.L. Orr, I.V. Perevoshchikova, J.R. Treberg, B.A. Ackrell, M.D. Brand, Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions, J. Biol. Chem. 287 (2012) 27255-27264. source
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 45
- Probably not a substantial claim. 33
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Importantly, the modulation of mitochondrial ROS production was independent of K + -ions, indicating that a putative mitoK ATP channel was not involved.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.3. Is a mitochondrial K ATP channel involved in cardioprotective preconditioning?
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In addition, similar atpenin A5 concentrations stimulated the superoxide production at the Q o site of antimycin A inhibited complex III, which may represent the source of 'signaling ROS' during ischemic and pharmacological preconditioning [15].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.3. Is a mitochondrial K ATP channel involved in cardioprotective preconditioning?
What the sources say
- Not checked yetcites [15] 15. S. Dröse, P.J. Hanley, U. Brandt, Ambivalent effects of diazoxide on mitochondrial ROS production at respiratory chain complexes I and III, Biochim. Biophys. Acta 1790 (2009) 558-565. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“However, some mutations in complex II subunits that have been linked to specific forms of cancer or neurodegeneration can lead to an increased ROS generation (reviewed in [12][13][14]).”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 1. Introduction
What the sources say
- Not checked yetcites [12][13][14]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The respiratory chain provides the main portion of ATP in eukaryotic cells, but is also a major source of reactive oxygen species (ROS) [2][3][4][5][6].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 1. Introduction
What the sources say
- Not checked yetcites [2][3][4][5][6]
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Mitochondrial complex II (succinate:ubiquinone oxidoreductase; succinate dehydrogenase, SDH) oxidizes succinate to fumarate and reduces ubiquinone, thereby creating a direct link between the tricarboxylic acid (TCA) cycle (also known as citric acid or Krebs cycle) and the respiratory chain [1] (Fig. 1).”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 1. Introduction
What the sources say
- Not checked yetcites [1] 1. G. Cecchini, Function and structure of complex II of the respiratory chain, Annu. Rev. Biochem. 72 (2003) 77-109. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Within the respiratory chain, complexes I (NADH:ubiquinone oxidoreductase) and III (ubiquinol:cytochrome c oxidoreductase; cytochrome bc 1 complex) are generally regarded as the main ROS sources, while the contribution of intact complex II seems to be negligible [3][4][5][6].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 1. Introduction
What the sources say
- Not checked yetcites [3][4][5][6]
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“This seems to be especially the case for mutations in complex II subunits C and D located in the vicinity of the Qp site that have been associated with specific forms of cancer such as hereditary paragangliomas and pheochromocytomas (overview in [13,14,36]) and in SdhA that can cause Leigh syndrome, a progressive neurodegenerative disease [14,94].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [13] 13. C. Bardella, P.J. Pollard, I. Tomlinson, SDH mutations in cancer, Biochim. Biophys. Acta 1807 (2011) 1432-1443. source
- Not checked yetcites [14] 14. T.M. Iverson, E. Maklashina, G. Cecchini, Structural basis for malfunction in com- plex II, J. Biol. Chem. 287 (2012) 35430-35438. source
- Not checked yetcites [36] 36. S.J. Ralph, R. Moreno-Sanchez, J. Neuzil, S. Rodriguez-Enriquez, Inhibitors of suc- cinate: quinone reductase/complex II regulate production of mitochondrial re- active oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death, Pharm. Res. 28 (2011) 2695-2730. source
- Not checked yetcites [94] 94. B.A. Ackrell, Cytopathies involving mitochondrial complex II, Mol. Aspects Med. 23 (2002) 369-384. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“This increased succinate pool under hypoxia might be supplied either from glutamate through α-ketoglutarate by transamination [76,77] or by a partial reversal of the TCA cycle from malate through fumarate, which requires that complex II would become a fumarate reductase under hypoxia [36,79].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 2.2. Complex II links the TCA cycle to the respiratory chain
What the sources say
- Not checked yetcites [76] 76. R.J. Wiesner, P. Rosen, M.K. Grieshaber, Pathways of succinate formation and their contribution to improvement of cardiac-function in the hypoxic rat-heart, Biochem. Med. Metab. Biol. 40 (1988) 19-34. source
- Not checked yetcites [77] 77. R.J. Wiesner, A. Deussen, M. Borst, J. Schrader, M.K. Grieshaber, Glutamate degra- dation in the ischemic dog heart -contribution to anaerobic energy-production, J. Mol. Cell. Cardiol. 21 (1989) 49-59. source
- Not checked yetcites [36] 36. S.J. Ralph, R. Moreno-Sanchez, J. Neuzil, S. Rodriguez-Enriquez, Inhibitors of suc- cinate: quinone reductase/complex II regulate production of mitochondrial re- active oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death, Pharm. Res. 28 (2011) 2695-2730. source
- Not checked yetcites [79] 79. C. Hohl, R. Oestreich, P. Rosen, R. Wiesner, M. Grieshaber, Evidence for succinate production by reduction of fumarate during hypoxia in isolated adult-rat heart-cells, Arch. Biochem. Biophys. 259 (1987) 527-535. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“E. coli SQR exclusively produces superoxide.In contrast, E. coli QFR produces mainly superoxide at lower succinate concentrations and comparably more hydrogen peroxide at higher substrate concentrations [101].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [101] 101. K.R. Messner, J.A. Imlay, Mechanism of superoxide and hydrogen peroxide for- mation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase, J. Biol. Chem. 277 (2002) 42563-42571. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“They proposed a mechanism for ROS production by complex II that relies upon the occupancy of the carboxylate binding site and the reduction state of the enzyme, i.e.ROS are only generated when the flavin is reduced and the carboxylate binding site is not occupied.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [37] 37. C.L. Quinlan, A.L. Orr, I.V. Perevoshchikova, J.R. Treberg, B.A. Ackrell, M.D. Brand, Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions, J. Biol. Chem. 287 (2012) 27255-27264. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“Furthermore, both enzymes showed maximal rates of ROS at intermediate succinate concentrations between 0.1 and 1 mM and decreased rates at lower and higher substrate concentration, which resembles the dependence found later for mammalian [37] and nematode [100] complex II.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [37] 37. C.L. Quinlan, A.L. Orr, I.V. Perevoshchikova, J.R. Treberg, B.A. Ackrell, M.D. Brand, Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions, J. Biol. Chem. 287 (2012) 27255-27264. source
- Not checked yetcites [100] 100. M.P. Paranagama, K. Sakamoto, H. Amino, M. Awano, H. Miyoshi, K. Kita, Contri- bution of the FAD and quinone binding sites to the production of reactive oxy- gen species from Ascaris suum mitochondrial complex II, Mitochondrion 10 (2010) 158-165. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The activity of complex II is directly influenced by the concentration of other TCA cycle metabolites, since malate, fumarate, citrate and especially oxaloacetate [65][66][67] have been shown to inhibit competitively with succinate.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 2.2. Complex II links the TCA cycle to the respiratory chain
What the sources say
- Not checked yetcites [65][66][67]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Furthermore, this ROS production was completely sensitive to the competitive carboxylate site inhibitor malonate and was only partially repressed by the Q-site inhibitor atpenin A5.Therefore, the authors concluded that the ROS must have been produced at the flavin site of complex II [37].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [37] 37. C.L. Quinlan, A.L. Orr, I.V. Perevoshchikova, J.R. Treberg, B.A. Ackrell, M.D. Brand, Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions, J. Biol. Chem. 287 (2012) 27255-27264. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
In the paper
“Messner and Imlay concluded that QFR releases superoxide from the fully reduced flavin if the [2Fe-2S] cluster is available to sequester the semiquinone electron; otherwise this electron is rapidly transferred to the nascent superoxide and hydrogen peroxide is released [101].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [101] 101. K.R. Messner, J.A. Imlay, Mechanism of superoxide and hydrogen peroxide for- mation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase, J. Biol. Chem. 277 (2002) 42563-42571. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“An ambivalence of mitochondrial ROS production has been also detected in the context of ischemia/reperfusion and ischemic or pharmacological preconditioning: while reactive oxygen species are among the main determinants of cellular damage during longer periods of ischemia and reperfusion, there is also ample evidence that mitochondrial ROS production is involved in cardioprotective signaling”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 1. Introduction
What the sources say
- Not checked yetcites [8,[38][39][40]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“The protective effects of complex II inhibitors could then be explained by their differential effects on complex I and complex III related ROS production: they reduce ROS that are generated at complex I by reverse electron transfer (RET) during reperfusion while they promote production of ROS at the Q o site of complex III by shifting the redox state of the Q-pool to an intermediate state [15].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 1. Introduction
What the sources say
- Not checked yetcites [15] 15. S. Dröse, P.J. Hanley, U. Brandt, Ambivalent effects of diazoxide on mitochondrial ROS production at respiratory chain complexes I and III, Biochim. Biophys. Acta 1790 (2009) 558-565. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The mechanisms of complex II-related ROS production observed in isolated mitochondria, submitochondrial particles, bacteria, and nematodes are representative of mammalian cardiac mitochondria relevant to ischemia/reperfusion and preconditioning.
None of the sources cited for this claim have been checked yet.
In the paper
“In coupled mitochondria and SMP, high ROS production is observed under these conditions, but this can be largely attributed to complex I due to reverse electron transfer from complex II, since (i) it is sensitive to complex I inhibitors like rotenone [18][19][20]24,91,92], (ii) requires a high membrane potential, i.e. is sensitive to uncouplers and ionophores [15,[18][19][20]91] or ADP (that”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [18][19][20]24,91,92]
- Not checked yetcites [15,[18][19][20]91]
- Not checked yetcites [32] 32. S. Dröse, U. Brandt, The mechanism of mitochondrial superoxide production by the cytochrome bc 1 complex, J. Biol. Chem. 283 (2008) 21649-21654. source
- Not checked yetcites [93] 93. Q. Chen, E.J. Vazquez, S. Moghaddas, C.L. Hoppel, E.J. Lesnefsky, Production of re- active oxygen species by mitochondria: central role of complex III, J. Biol. Chem. 278 (2003) 36027-36031. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“The succinate-dependent ROS generation of SMP from adult worms, that do not contain complex III and IV activities in their respiratory chain, was not influenced by a complex I inhibitor and was completely and partially suppressed by malonate or atpenin A5, respectively.This indicates that complex II is the exclusive ROS source under these conditions.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [100] 100. M.P. Paranagama, K. Sakamoto, H. Amino, M. Awano, H. Miyoshi, K. Kita, Contri- bution of the FAD and quinone binding sites to the production of reactive oxy- gen species from Ascaris suum mitochondrial complex II, Mitochondrion 10 (2010) 158-165. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“This was also confirmed by Quinlan et al. [37], however these authors also observed that complex II in isolated rat skeletal mitochondria produced ROS at a significant rate with succinate concentrations below 5 mM (with a peak at around 400 μM) and when the downstream respiratory chain was inhibited.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [37] 37. C.L. Quinlan, A.L. Orr, I.V. Perevoshchikova, J.R. Treberg, B.A. Ackrell, M.D. Brand, Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions, J. Biol. Chem. 287 (2012) 27255-27264. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Finally, it was shown that the complex II related rates approach or exceed the maximum rates of complexes I and III indicating that complex II may be an important contributor to physiological and pathological ROS production [37].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [37] 37. C.L. Quinlan, A.L. Orr, I.V. Perevoshchikova, J.R. Treberg, B.A. Ackrell, M.D. Brand, Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions, J. Biol. Chem. 287 (2012) 27255-27264. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Both enzymes produced ROS with a linear dependence on the dissolved oxygen concentration, although SQR produced ROS at a much lower rate.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [101] 101. K.R. Messner, J.A. Imlay, Mechanism of superoxide and hydrogen peroxide for- mation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase, J. Biol. Chem. 277 (2002) 42563-42571. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Besides a direct competition between succinate and malate, it has been observed that complex II can oxidize malate to the enol form oxaloacetate [67,68], which binds to the dicarboxylate binding site with high affinity [66].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 2.2. Complex II links the TCA cycle to the respiratory chain
What the sources say
- Not checked yetcites [67] 67. B.A.C. Ackrell, E.B. Kearney, M. Mayr, Studies on succinate-dehydrogenase. 24. Role of oxalacetate in regulation of mammalian succinate-dehydrogenase, J. Biol. Chem. 249 (1974) 2021-2027. source
- Not checked yetcites [68] 68. Y.O. Belikova, A.B. Kotlyar, A.D. Vinogradov, Oxidation of malate by the mitochon- drial succinate-ubiquinone reductase, Biochim. Biophys. Acta 936 (1988) 1-9. source
- Not checked yetcites [66] 66. E.B. Kearney, B.A.C. Ackrell, M. Mayr, Tightly bound oxalacetate and activation of succinated dehydrogenase, Biochem. Biophys. Res. Commun. 49 (1972) 1115-1121. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The succinate concentration in different tissues and mitochondria is in the submillimolar range under aerobic conditions [22,72,73], indicating that complex II is not working at maximal velocity under 'standard conditions'.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 2.2. Complex II links the TCA cycle to the respiratory chain
What the sources say
- Not checked yetcites [22] 22. A.A. Starkov, The role of mitochondria in reactive oxygen species metabolism and signaling, Ann. N. Y. Acad. Sci. 1147 (2008) 37-52. source
- Not checked yetcites [72] 72. S. Hoyer, C. Krier, Ischemia and the aging brain -studies on glucose and energy-metabolism in rat cerebral-cortex, Neurobiol. Aging 7 (1986) 23-29. source
- Not checked yetcites [73] 73. K. Brockmann, A. Bjornstad, P. Dechent, C.G. Korenke, J. Smeitink, J.M.F. Trijbels, S. Athanassopoulos, R. Villagran, O.H. Skjeldal, E. Wilichowski, J. Frahm, F. Hanefeld, Succinate in dystrophic white matter: a proton magnetic resonance spectroscopy finding characteristic for complex II deficiency, Ann. Neurol. 52 (2002) 38-46. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“This can be explained by an increased oxidation of the Q-pool, since it was shown that the superoxide generation at the Q o site is maximal at intermediate reduction states of the ubiquinone pool if the Q i site is blocked by antimycin A [25,32,33].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.2. Complex II as a modulator of the ROS production by complexes I and III
What the sources say
- Not checked yetcites [25] 25. L. Bleier, S. Dröse, Superoxide generation by complex III: from mechanistic rationales to functional consequences, Biochim. Biophys, Acta (2013), http://dx.doi.org/10. 1016/j.bbabio.2012.12.002. source
- Not checked yetcites [32] 32. S. Dröse, U. Brandt, The mechanism of mitochondrial superoxide production by the cytochrome bc 1 complex, J. Biol. Chem. 283 (2008) 21649-21654. source
- Not checked yetcites [33] 33. C.L. Quinlan, A.A. Gerencser, J.R. Treberg, M.D. Brand, The mechanism of super- oxide production by the antimycin-inhibited mitochondrial Q-cycle, J. Biol. Chem. 286 (2011) 31361-31372. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In SQR the high potential centers ([3Fe-4S] and heme b, which attract electrons and pull them away from the dicarboxylate site) are close to the Q site, while in QFR, FAD and the [2Fe-2S] clusters have the highest redox potentials and hence accumulate electrons close to the dicarboxylate binding site.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [12] 12. V. Yankovskaya, R. Horsefield, S. Tornroth, C. Luna-Chavez, C. Leger, B. Byrne, G. Cecchini, S. Iwata, Architecture of succinate dehydrogenase and reactive oxygen species generation, Science 299 (2003) 700-704. source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“it was suggested by Muller et al. that the differential contribution of TCA cycle enzymes and the conditional removal of the endogenous complex II inhibitor oxaloacetate are key factors that control succinate-dependent ROS generation [23].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.2. Complex II as a modulator of the ROS production by complexes I and III
What the sources say
- Not checked yetcites [23] 23. F.L. Muller, Y.H. Liu, M.A. Abdul-Ghani, M.S. Lustgarten, A. Bhattacharya, Y.C. Jang, H. Van Remmen, High rates of superoxide production in skeletal-muscle mitochondria respiring on both complex I-and complex II-linked substrates, Biochem. J. 409 (2008) 491-499. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✗ Asserted: fails✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The authors may not put it forward as true. The paper’s conclusions may not depend on it.
In the paper
“Zoccarato and colleagues have shown that under these conditions electrons can flow downstream through complex I, which should attenuate RET [21].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.2. Complex II as a modulator of the ROS production by complexes I and III
What the sources say
- Not checked yetcites [21] 21. F. Zoccarato, L. Cavallini, S. Bortolami, A. Alexandre, Succinate modulation of H 2 O 2 release at NADH:ubiquinone oxidoreductase (complex I) in brain mito- chondria, Biochem. J. 406 (2007) 125-129. source
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“They have proposed that the reduction of the succinate-dependent ROS formation by malate is due to an accumulation of oxaloacetate that occurs unless acetyl-CoA is available.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.2. Complex II as a modulator of the ROS production by complexes I and III
What the sources say
- Not checked yetcites [23] 23. F.L. Muller, Y.H. Liu, M.A. Abdul-Ghani, M.S. Lustgarten, A. Bhattacharya, Y.C. Jang, H. Van Remmen, High rates of superoxide production in skeletal-muscle mitochondria respiring on both complex I-and complex II-linked substrates, Biochem. J. 409 (2008) 491-499. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✗ Asserted: fails✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The authors may not put it forward as true. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“other studies demonstrated that different NADH-generating substrates have an opposing effect on ROS generation [23,35,108]”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.2. Complex II as a modulator of the ROS production by complexes I and III
What the sources say
- Not checked yetcites [23] 23. F.L. Muller, Y.H. Liu, M.A. Abdul-Ghani, M.S. Lustgarten, A. Bhattacharya, Y.C. Jang, H. Van Remmen, High rates of superoxide production in skeletal-muscle mitochondria respiring on both complex I-and complex II-linked substrates, Biochem. J. 409 (2008) 491-499. source
- Not checked yetcites [35] 35. F. Zoccarato, C. Miotto, L. Cavallini, A. Alexandre, The control of mitochon- drial succinate-dependent H 2 O 2 production, J. Bioenerg. Biomembr. 43 (2011) 359-366. source
- Not checked yetcites [108] 108. S. Bortolami, E. Comelato, F. Zoccarato, A. Alexandre, L. Cavallini, Long chain fatty acyl-CoA modulation of H 2 O 2 release at mitochondrial complex I, J. Bioenerg. Biomembr. 40 (2008) 9-18. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“In principle, fully reduced FAD can either transfer one electron onto molecular oxygen which leads to the formation of superoxide (probably the major reaction in complex II, but only confirmed for E. coli SQR [101]) or it may also transfer both electrons onto O 2 which leads to the formation of H 2 O 2 (as shown for E. coli QFR [101]) (Fig. 2B).”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [101] 101. K.R. Messner, J.A. Imlay, Mechanism of superoxide and hydrogen peroxide for- mation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase, J. Biol. Chem. 277 (2002) 42563-42571. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Mutants of E. coli SQR that do not contain heme b showed an unchanged ROS generation, indicating that this prosthetic group is not serving as a 'sink' for excess electrons [102,103].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [102] 102. Q.M. Tran, R.A. Rothery, E. Maklashina, G. Cecchini, J.H. Weiner, Escherichia coli suc- cinate dehydrogenase variant lacking the heme b, Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 18007-18012. source
- Not checked yetcites [103] 103. Q.M. Tran, C. Fong, R.A. Rothery, E. Maklashina, G. Cecchini, J.H. Weiner, Out of plane distortions of the heme b of Escherichia coli succinate dehydrogenase, PLoS One 7 (2012). source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Yankovskaya et al. [12] proposed that the key difference in the ROS production by E. coli SQR and QFR lies in the differential arrangement of redox potentials among the redox centers.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [12] 12. V. Yankovskaya, R. Horsefield, S. Tornroth, C. Luna-Chavez, C. Leger, B. Byrne, G. Cecchini, S. Iwata, Architecture of succinate dehydrogenase and reactive oxygen species generation, Science 299 (2003) 700-704. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“While alternative explanations for the source or mechanism of ROS production under these conditions have been proposed [34,36], the prevalent view is that under these conditions ROS are produced by complex I due to RET from complex II [18][19][20]23].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.2. Complex II as a modulator of the ROS production by complexes I and III
What the sources say
- Not checked yetcites [34] 34. F. Zoccarato, L. Cavallini, A. Alexandre, Succinate is the controller of O 2 -•/H 2 O 2 release at mitochondrial complex I: negative modulation by malate, positive by cyanide, J. Bioenerg. Biomembr. 41 (2009) 387-393. source
- Not checked yetcites [36] 36. S.J. Ralph, R. Moreno-Sanchez, J. Neuzil, S. Rodriguez-Enriquez, Inhibitors of suc- cinate: quinone reductase/complex II regulate production of mitochondrial re- active oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death, Pharm. Res. 28 (2011) 2695-2730. source
- Not checked yetcites [18][19][20]23]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
In the paper
“While these arrangements favor the respective physiological activity (i.e., ubiquinone reduction for SQR and fumarate reduction/menaquinol oxidation for QFR) they also presuppose a differential disposition for superoxide production under aerobic conditions.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [12] 12. V. Yankovskaya, R. Horsefield, S. Tornroth, C. Luna-Chavez, C. Leger, B. Byrne, G. Cecchini, S. Iwata, Architecture of succinate dehydrogenase and reactive oxygen species generation, Science 299 (2003) 700-704. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“While a contribution of the Q site might occur in the respective mutants, the most likely source of ROS in wild-type complex II is the fully reduced FAD [37,101].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.1. Complex II as a source of ROS
What the sources say
- Not checked yetcites [37] 37. C.L. Quinlan, A.L. Orr, I.V. Perevoshchikova, J.R. Treberg, B.A. Ackrell, M.D. Brand, Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions, J. Biol. Chem. 287 (2012) 27255-27264. source
- Not checked yetcites [101] 101. K.R. Messner, J.A. Imlay, Mechanism of superoxide and hydrogen peroxide for- mation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase, J. Biol. Chem. 277 (2002) 42563-42571. source
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“However, atpenin A5 induced ROS generation by complex II was somewhat lower than ROS generation induced by a further downstream block (at the complex III Q o site by myxothialzol), which has been explained by an alteration of the succinate dehydrogenase activity upon atpenin A5 binding [37].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.2. Complex II as a modulator of the ROS production by complexes I and III
What the sources say
- Not checked yetcites [37] 37. C.L. Quinlan, A.L. Orr, I.V. Perevoshchikova, J.R. Treberg, B.A. Ackrell, M.D. Brand, Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions, J. Biol. Chem. 287 (2012) 27255-27264. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Recent investigations indicate that mitochondria are not only an important source of ROS, but can also scavenge large quantities of internally and externally produced reactive oxygen species, especially hydrogen peroxide [22,[111][112][113][114][115][116].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.3. Complex II and the antioxidative defense
What the sources say
- Not checked yetcites [22,[111][112][113][114][115][116]
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Accordingly, inhibition of complex II and attenuation of the succinate supported ROS generation have been shown by Dzeja et al. [130].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.2. Ambivalent roles of complex II and ROS in cardioprotective preconditioning and I/R injury
What the sources say
- Not checked yetcites [130] 130. P.P. Dzeja, P. Bast, C. Ozcan, A. Valverde, E.L. Holmuhamedov, D.G.L. Van Wylen, A. Terzic, Targeting nucleotide-requiring enzymes: implications for diazoxide-induced cardioprotection, Am. J. Physiol. 284 (2003) H1048-H1056.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Alternatively, the substrate flow through the TCA cycle differs depending on the substrates, which might affect the activity of the other two mitochondrial NADPH-regenerating enzymes the NADP + -dependent isocitrate dehydrogenase [119,120] and the malic enzyme [118,121].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.3. Complex II and the antioxidative defense
What the sources say
- Not checked yetcites [119] 119. L.A. Sazanov, J.B. Jackson, Proton-translocating transhydrogenase and NAD- linked and NADP-linked isocitrate dehydrogenases operate in a substrate cycle which contributes to fine regulation of the tricarboxylic-acid cycle activity in mitochondria, FEBS Lett. 344 (1994) 109-116. source
- Not checked yetcites [120] 120. S.H. Jo, M.K. Son, H.J. Koh, S.M. Lee, I.H. Song, Y.O. Kim, Y.S. Lee, K.S. Jeong, W.B. Kim, J.W. Park, B.J. Song, T.L. Huh, Control of mitochondrial redox balance and cellular defense against oxidative damage by mitochondrial NADP + -dependent isocitrate dehydrogenase, J. Biol. Chem. 276 (2001) 26732. source
- Not checked yetcites [118] 118. J. Rydström, Mitochondrial NADPH, transhydrogenase and disease, Biochim. Biophys. Acta 1757 (2006) 721-726. source
- Not checked yetcites [121] 121. W.H. Ying, NAD + /NADH and NADP + /NADPH in cellular functions and cell death: regulation and biological consequences, Antioxid. Redox Signal. 10 (2008) 179-206. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“They identified uncouplers and complex I inhibitors as compounds that attenuate the ROS-induced damage in I/R-hearts.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.2. Ambivalent roles of complex II and ROS in cardioprotective preconditioning and I/R injury
What the sources say
- Not checked yetcites [123] 123. Q. Chen, A.K.S. Camara, D.F. Stowe, C.L. Hoppel, E.J. Lesnefsky, Modulation of electron transport protects cardiac mitochondria and decreases myocardial in- jury during ischemia and reperfusion, Am. J. Physiol. 292 (2007) C137-C147. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Hence, the overall ROS release from isolated mitochondria might appear almost unchanged, yet the ROS production is shifted from complex I to complex III.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.2. Complex II as a modulator of the ROS production by complexes I and III
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Ischemic preconditioning can be mimicked by the K ATP channel opener diazoxide and various other substances, a phenomenon termed pharmacological preconditioning [39].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.1. Brief introduction to ischemia/reperfusion and the phenomena of pre-and postconditioning
What the sources say
- Not checked yetcites [39] 39. P.J. Hanley, J. Daut, K ATP channels and preconditioning: a re-examination of the role of mitochondrial K ATP channels and an overview of alternative mechanisms, J. Mol. Cell. Cardiol. 39 (2005) 17-50. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“The highly effective mitochondrial antioxidative defense system encompasses the thioredoxin/peroxiredoxin system as well as the glutathione/glutathione peroxidase system (overview in [22,117]).”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.3. Complex II and the antioxidative defense
What the sources say
- Not checked yetcites [22] 22. A.A. Starkov, The role of mitochondria in reactive oxygen species metabolism and signaling, Ann. N. Y. Acad. Sci. 1147 (2008) 37-52. source
- Not checked yetcites [117] 117. C.C. Winterbourn, M.B. Hampton, Thiol chemistry and specificity in redox sig- naling, Free Radic. Biol. Med. 45 (2008) 549-561. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Diazoxide transiently induces increased ROS production [43,[131][132][133], which is in agreement with the view that mitochondria-derived reactive oxygen species are involved in cardioprotective signaling during ischemic and pharmacological preconditioning (overview in [8,39,40]).”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.2. Ambivalent roles of complex II and ROS in cardioprotective preconditioning and I/R injury
What the sources say
- Not checked yetcites [43,[131][132][133]
- Not checked yetcites [8] 8. A.P. Halestrap, S.J. Clarke, I. Khaliulin, The role of mitochondria in protection of the heart by preconditioning, Biochim. Biophys. Acta 1767 (2007) 1007-1031. source
- Not checked yetcites [39] 39. P.J. Hanley, J. Daut, K ATP channels and preconditioning: a re-examination of the role of mitochondrial K ATP channels and an overview of alternative mechanisms, J. Mol. Cell. Cardiol. 39 (2005) 17-50. source
- Not checked yetcites [40] 40. L.S. Burwell, S.M. Nadtochiy, P.S. Brookes, Cardioprotection by metabolic shut-down and gradual wake-up, J. Mol. Cell. Cardiol. 46 (2009) 804-810. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“It has been recognized that the mitochondria are both targets and sources of injury during cardiac ischemia and reperfusion [123].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.1. Brief introduction to ischemia/reperfusion and the phenomena of pre-and postconditioning
What the sources say
- Not checked yetcites [123] 123. Q. Chen, A.K.S. Camara, D.F. Stowe, C.L. Hoppel, E.J. Lesnefsky, Modulation of electron transport protects cardiac mitochondria and decreases myocardial in- jury during ischemia and reperfusion, Am. J. Physiol. 292 (2007) C137-C147. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“ROS production under these conditions is therefore not only attenuated by both classes of complex II inhibitors, but also by uncouplers, ionophores and complex I inhibitors.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.2. Complex II as a modulator of the ROS production by complexes I and III
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“However, the damage occurring during ischemia/reperfusion (I/R) can be reduced by ischemic preconditioning where the prolonged ischemic period is preceded by one or more brief (2-5 min) cycles of ischemia and reperfusion [8,39,124].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.1. Brief introduction to ischemia/reperfusion and the phenomena of pre-and postconditioning
What the sources say
- Not checked yetcites [8] 8. A.P. Halestrap, S.J. Clarke, I. Khaliulin, The role of mitochondria in protection of the heart by preconditioning, Biochim. Biophys. Acta 1767 (2007) 1007-1031. source
- Not checked yetcites [39] 39. P.J. Hanley, J. Daut, K ATP channels and preconditioning: a re-examination of the role of mitochondrial K ATP channels and an overview of alternative mechanisms, J. Mol. Cell. Cardiol. 39 (2005) 17-50. source
- Not checked yetcites [124] 124. D.M. Yellon, J.M. Downey, Preconditioning the myocardium: from cellular phys- iology to clinical cardiology, Phys. Rev. 83 (2003) 1113-1151. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A high succinate concentration and elevated complex II activity will suppress ROS generation from FAD, but will induce superoxide production at complex I due to RET (Fig. 3A).”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 3.2. Complex II as a modulator of the ROS production by complexes I and III
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Diazoxide as well as several very brief ischemic intervals (10 s) during the early phase of reperfusion also improve the recovery of the heart and reduce infarct size, a phenomenon termed postconditioning [8].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.1. Brief introduction to ischemia/reperfusion and the phenomena of pre-and postconditioning
What the sources say
- Not checked yetcites [8] 8. A.P. Halestrap, S.J. Clarke, I. Khaliulin, The role of mitochondria in protection of the heart by preconditioning, Biochim. Biophys. Acta 1767 (2007) 1007-1031. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“This site has been considered as a source for mitochondria-derived 'signaling ROS' in several cellular processes including the stabilization of the hypoxia-inducible factor 1-α [135][136][137].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.2. Ambivalent roles of complex II and ROS in cardioprotective preconditioning and I/R injury
What the sources say
- Not checked yetcites [135][136][137]
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Importantly, diazoxide and ischemic preconditioning associated ROS production is attenuated by myxothiazol [132,134], which clearly indicates that the Q o site of complex III is the source.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.2. Ambivalent roles of complex II and ROS in cardioprotective preconditioning and I/R injury
What the sources say
- Not checked yetcites [132] 132. O. Oldenburg, M.V. Cohen, J.M. Downey, Mitochondrial K ATP channels in preconditioning, J. Mol. Cell. Cardiol. 35 (2003) 569-575. source
- Not checked yetcites [134] 134. T.L. Vanden Hoek, L.B. Becker, Z. Shao, C. Li, P.T. Schumacker, Reactive oxygen spe- cies released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes, J. Biol. Chem. 273 (1998) 18092-18098. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“It seems plausible that both substance groups exert their protective effects by suppressing the RET-induced superoxide production by complex I (Section 3.2), but Chen et al. suggested complex III as the source of ROS [123].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.2. Ambivalent roles of complex II and ROS in cardioprotective preconditioning and I/R injury
What the sources say
- Not checked yetcites [123] 123. Q. Chen, A.K.S. Camara, D.F. Stowe, C.L. Hoppel, E.J. Lesnefsky, Modulation of electron transport protects cardiac mitochondria and decreases myocardial in- jury during ischemia and reperfusion, Am. J. Physiol. 292 (2007) C137-C147. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“It is well known that a prolonged period of ischemia followed by reperfusion irreversibly damages the heart and other tissues (overview in [8,9]).”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.1. Brief introduction to ischemia/reperfusion and the phenomena of pre-and postconditioning
What the sources say
- Not checked yetcites [8] 8. A.P. Halestrap, S.J. Clarke, I. Khaliulin, The role of mitochondria in protection of the heart by preconditioning, Biochim. Biophys. Acta 1767 (2007) 1007-1031. source
- Not checked yetcites [9] 9. D.M. Yellon, D.J. Hausenloy, Mechanisms of disease: myocardial reperfusion in- jury, N. Engl. J. Med. 357 (2007) 1121-1135. source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“During ischemia, only a small increase of ROS has been detected, but a burst occurs upon reperfusion [43,125].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.2. Ambivalent roles of complex II and ROS in cardioprotective preconditioning and I/R injury
What the sources say
- Not checked yetcites [43] 43. P. Pasdois, B. Beauvoit, L. Tariosse, B. Vinassa, S. Bonoron-Adele, P. Dos Santos, Effect of diazoxide on flavoprotein oxidation and reactive oxygen species gener- ation during ischemia-reperfusion: a study on Langendorff-perfused rat hearts using optic fibers, Am. J. Physiol. 294 (2008) H2088-H2097.
- Not checked yetcites [125] 125. L.G. Kevin, A.K.S. Camara, M.L. Riess, E. Novalija, D.F. Stowe, Ischemic preconditioning alters real-time measure of O 2 radicals in intact hearts with is- chemia and reperfusion, Am. J. Physiol. 284 (2003) H566-H574.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, there is general uncertainty whether the applied concentration in various test systems will result in similar effective concentrations, which might be largely influenced by the partition coefficient and relative membrane permeability of the applied drug.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.3. Is a mitochondrial K ATP channel involved in cardioprotective preconditioning?
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Alternatively, diazoxide that probably binds to the Qp site of complex II (unpublished results) might directly induce ROS generation at the FAD at relatively low succinate concentrations (Fig. 3C).”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.2. Ambivalent roles of complex II and ROS in cardioprotective preconditioning and I/R injury
What the sources say
- Not checked yetcites unpublished results
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
In the paper
“It has been pointed out that the effects of diazoxide on mitochondrial respiration occur at concentrations that are above the concentrations that are usually applied for mitoK ATP opening [151].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.3. Is a mitochondrial K ATP channel involved in cardioprotective preconditioning?
What the sources say
- Not checked yetcites [151] 151. A.J. Kowaltowski, S. Seetharaman, P. Paucek, K.D. Garlid, Bioenergetic conse- quences of opening the ATP-sensitive K + channel of heart mitochondria, Am. J. Physiol. 280 (2001) H649-H657.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Hence, it is uncertain whether this mechanism correctly describes ROS generation in vivo.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.2. Ambivalent roles of complex II and ROS in cardioprotective preconditioning and I/R injury
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“It was concluded from many investigations that diazoxide targets a mitochondrial form of ATP-dependent K + channels (mitoK ATP ) and that this channel plays a central role in cardioprotection by ischemic and pharmacological preconditioning and by ischemic postconditioning [140][141][142].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.3. Is a mitochondrial K ATP channel involved in cardioprotective preconditioning?
What the sources say
- Not checked yetcites [140][141][142]
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“The effect of atpenin A5 was independent of complex II inhibition, and the authors suggested that opening of the putative mitoK ATP channel is the underlying mechanism.”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.3. Is a mitochondrial K ATP channel involved in cardioprotective preconditioning?
What the sources say
- Not checked yetcites [44] 44. A.P. Wojtovich, P.S. Brookes, The complex II inhibitor atpenin A5 protects against cardiac ischemia-reperfusion injury via activation of mitochondrial K-ATP channels, Basic Res. Cardiol. 104 (2009) 121-129. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
In the paper
“Hence, an alternative hypothesis was presented that relates the cardioprotective effects of atpenins to the modulation of mitochondrial ROS production [16].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.3. Is a mitochondrial K ATP channel involved in cardioprotective preconditioning?
What the sources say
- Not checked yetcites [16] 16. S. Dröse, L. Bleier, U. Brandt, A common mechanism links differently acting com- plex II inhibitors to cardioprotection: modulation of mitochondrial reactive ox- ygen species production, Mol. Pharmacol. 79 (2011) 814-822. source
Tests✗ Asserted: fails✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. The authors may not put it forward as true.
None of the sources cited for this claim have been checked yet.
In the paper
“Recently, a model was presented that merges these two conflicting views, i.e. that complex II may be a component or regulator of the mitoK ATP channel [44,156,157].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.3. Is a mitochondrial K ATP channel involved in cardioprotective preconditioning?
What the sources say
- Not checked yetcites [44] 44. A.P. Wojtovich, P.S. Brookes, The complex II inhibitor atpenin A5 protects against cardiac ischemia-reperfusion injury via activation of mitochondrial K-ATP channels, Basic Res. Cardiol. 104 (2009) 121-129. source
- Not checked yetcites [156] 156. H. Ardehali, Z.H. Chen, Y. Ko, R. Mejia-Alvarez, E. Marban, Multiprotein complex containing succinate dehydrogenase confers mitochondrial ATP-sensitive K + channel activity, Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11880-11885. source
- Not checked yetcites [157] 157. A.P. Wojtovich, P.S. Brookes, The endogenous mitochondrial complex II inhibitor malonate regulates mitochondrial ATP-sensitive potassium channels: implications for ischemic preconditioning, Biochim. Biophys. Acta 1777 (2008) 882-889. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Especially, the fact that the K ATP channel subunits could not be identified so far in highly purified mitochondria challenges its existence [145,146].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.3. Is a mitochondrial K ATP channel involved in cardioprotective preconditioning?
What the sources say
- Not checked yetcites [145] 145. T. Brustovetsky, N. Shalbuyeva, N. Brustovetsky, Lack of manifestations of diazoxide/5-hydroxydecanoatesensitive K ATP channel in rat brain nonsynaptosomal mitochondria, J. Physiol. Lond. 568 (2005) 47-59. source
- Not checked yetcites [146] 146. D.B. Foster, J.J. Rucker, E. Marban, Is Kir6.1 a subunit of mitoK ATP ? Biochem. Biophys. Res. Commun. 366 (2008) 649-656. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Diazoxide inhibits complex II [128,129,147], while the K ATP channel antagonist 5-HD can be metabolized by the ß-oxidation pathway of the mitochondria [148][149][150].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.3. Is a mitochondrial K ATP channel involved in cardioprotective preconditioning?
What the sources say
- Not checked yetcites [128] 128. P.J. Hanley, M. Mickel, M. Löffler, U. Brandt, J. Daut, K ATP channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart, J. Physiol. 542 (2002) 735-741. source
- Not checked yetcites [129] 129. S. Dröse, U. Brandt, P.J. Hanley, K + -independent actions of diazoxide question the role of inner membrane K ATP channels in mitochondrial cytoprotective sig- naling, J. Biol. Chem. 281 (2006) 23733-23739. source
- Not checked yetcites [147] 147. S. Ovide-Bordeaux, R. Ventura-Clapier, V. Veksler, Do modulators of the mito- chondrial K ATP channel change the mitochondria in situ? J. Biol. Chem. 275 (2000) 37291-37295. source
- Not checked yetcites [148][149][150]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“However, the existence of such a mitoK ATP channel is controversial [8,39,[142][143][144].”
§ Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre-and postconditioning ☆ > 4.3. Is a mitochondrial K ATP channel involved in cardioprotective preconditioning?
What the sources say
- Not checked yetcites [8,39,[142][143][144]
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
The mechanisms of complex II-related ROS production observed in isolated mitochondria, submitochondrial particles, bacteria, and nematodes are representative of mammalian cardiac mitochondria relevant to ischemia/reperfusion and preconditioning.
“It is important to note that the overall structural and functional similarity of E. coli SQR and QFR to mammalian complex II has made them useful models systems for structure-function investigations and the analysis of disease-related human mutations [14].”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In sub-mitochondrial particles, it has been previously established that CII can produce ROS upon Q p site inhibition only when FAD is reduced and the dicarboxylate site is unoccupied.7,38”
From Ubiquinone-binding site mutagenesis reveals the role of mitochondrial complex II in cell death initiation (2015) · cites this paper as [38]
Experimental — accuracy not yet measured
Citations
Cites
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
Yellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Chandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Production of Reactive Oxygen Species by Mitochondria
Chen, Q., Vazquez, E. J., Moghaddas, S., Hoppel, C. L., & Lesnefsky, E. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304854200 · Cited by 1,616
The cellular production of hydrogen peroxide
Boveris, A., Oshino, N., & Chance, B. (1972) · Biochemical Journal · doi:10.1042/bj1280617 · Cited by 1,549
Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing
Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., Hammerling, U., & Schumacker, P. T. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.001 · Cited by 1,545
Ying, W. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1672 · Cited by 1,494
Supercomplexes in the respiratory chains of yeast and mammalian mitochondria
Schägger, H., & Pfeiffer, K. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1777 · Cited by 1,356
Flagged first, then by citations
1 of the 158 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Kalogeris, T. J., Bao, Y., & Korthuis, R. J. (2014) · Redox Biology · doi:10.1016/j.redox.2014.05.006 · Cited by 738
Free Radical Properties, Source and Targets, Antioxidant Consumption and Health
Martemucci, G., Costagliola, C., Mariano, M., D’Andrea, L., Napolitano, P., & D‘Alessandro, A. G. (2022) · Oxygen · doi:10.3390/oxygen2020006 · Cited by 854
Mitochondrial composition and function under the control of hypoxia
Fuhrmann, D. C., & Brüne, B. (2017) · Redox Biology · doi:10.1016/j.redox.2017.02.012 · Cited by 665
Functions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633
Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis
Tretter, L., Patócs, A., & Chinopoulos, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.03.012 · Cited by 550
Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment
Golpich, M., Amini, E., Mohamed, Z., Raymond, A. A., Ibrahim, N. M., & Ahmadiani, A. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12655 · Cited by 555
Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury
Fakhruddin, S., Alanazi, W. A., & Jackson, K. E. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8379327 · Cited by 300
Contribution of metabolic reprogramming to macrophage plasticity and function
Kasmi, K. C. E., & Stenmark, K. R. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.09.001 · Cited by 281
Chen, R., Lai, U. H., Zhu, L., Singh, A., AlKataan, M. A. A., & Forsyth, N. R. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00132 · Cited by 285
Mechanism of antineoplastic activity of lonidamine
Nath, K., Guo, L., Nancolas, B., NELSON, D. S., Shestov, A. A., Lee, S., Roman, J., Zhou, R., Leeper, D. B., Halestrap, A. P., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.08.001 · Cited by 219
Suppressors of superoxide production from mitochondrial complex III
Orr, A. L., Vargas, L., Turk, C. N., Baaten, J., Matzen, J., Dardov, V. J., Attle, S. J., Li, J., Quackenbush, D., Goncalves, R. L. S., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1910 · Cited by 207
Generator-specific targets of mitochondrial reactive oxygen species
Bleier, L., Wittig, I., Heide, H., Steger, M., Brandt, U., & Dröse, S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.10.511 · Cited by 188
Self-citationInsights into the respiratory chain and oxidative stress
Larosa, V., & Remacle, C. (2018) · Bioscience Reports · doi:10.1042/bsr20171492 · Cited by 192
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine
Guo, L., Shestov, A. A., Worth, A. J., Nath, K., NELSON, D. S., Leeper, D. B., Glickson, J. D., & Blair, I. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.697516 · Cited by 187
Roca, F. J., Whitworth, L. J., Prag, H. A., Murphy, M. P., & Ramakrishnan, L. (2022) · Science · doi:10.1126/science.abh2841 · Cited by 177
Mitochondrial complex II and reactive oxygen species in disease and therapy
Vanova, K. H., Kraus, M., Neužil, J., & Rohlena, J. (2020) · Redox Report · doi:10.1080/13510002.2020.1752002 · Cited by 166
Mitochondrial respiratory chain complexes as sources and targets of thiol-based redox-regulation
Dröse, S., Brandt, U., & Wittig, I. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.02.006 · Cited by 155
Self-citationControlling Redox Status for Stem Cell Survival, Expansion, and Differentiation
Sart, S., Song, L., & Li, Y. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/105135 · Cited by 143
Ischemic A/D transition of mitochondrial complex I and its role in ROS generation
Dröse, S., Степанова, А., & Galkin, A. S. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.12.013 · Cited by 140
Self-citationSiebels, I., & Dröse, S. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.06.005 · Cited by 130
Self-citationGuerra‐Castellano, A., Dı́az-Quintana, A., Pérez‐Mejías, G., Elena‐Real, C. A., González‐Arzola, K., García‐Mauriño, S. M., la Rosa, M. Á. D., & Díaz‐Moreno, I. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806833115 · Cited by 105
Cysteine-mediated redox signalling in the mitochondria
Bak, D. W., & Weerapana, E. (2014) · Molecular BioSystems · doi:10.1039/c4mb00571f · Cited by 102
Machine perfusion of the liver and bioengineering
Schlegel, A. A., Mergental, H., Fondevila, C., Porte, R. J., Friend, P. J., & Dutkowski, P. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.009 · Cited by 106
Guzzo, G., Sciacovelli, M., Bernardi, P., & Rasola, A. (2014) · Oncotarget · doi:10.18632/oncotarget.2472 · Cited by 100
Leishmania parasites exchange drug-resistance genes through extracellular vesicles
Douanne, N., Dong, G., Amin, A. B., Bernardo, L., Blanchette, M., Langlais, D., Olivier, M., & Fernandez‐Prada, C. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111121 · Cited by 92
The mitochondrial permeability transition pore and its adaptive responses in tumor cells
Rasola, A., & Bernardi, P. (2014) · Cell Calcium · doi:10.1016/j.ceca.2014.10.003 · Cited by 99
Florido, J., Martínez-Ruiz, L., Rodríguez-Santana, C., López‐Rodríguez, A., Hidalgo‐Gutiérrez, A., Cottet‐Rousselle, C., Lamarche, F., Schlattner, U., Guerra‐Librero, A., Aranda‐Martínez, P., et al. (2022) · Journal of Pineal Research · doi:10.1111/jpi.12824 · Cited by 89
Zhang, W., & Lang, R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1266973 · Cited by 88
Modica-Napolitano, J. S., & Weissig, V. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817394 · Cited by 80
Souders, C. L., Liang, X., Wang, X., Ector, N., Zhao, Y. H., & Martyniuk, C. J. (2018) · Aquatic Toxicology · doi:10.1016/j.aquatox.2018.03.031 · Cited by 74
Kuksal, N., Chalker, J., & Mailloux, R. J. (2017) · Biological Chemistry · doi:10.1515/hsz-2017-0160 · Cited by 74
Hardonnière, K., Saunier, E. F., Lemarié, A., Fernier, M., Gallais, I., Héliès‐Toussaint, C., Mograbi, B., Antonio, S., Bénit, P., Rustin, P., et al. (2016) · Scientific Reports · doi:10.1038/srep30776 · Cited by 72
Madungwe, N. B., Zilberstein, N., Feng, Y., & Bopassa, J. C. (2016) · PubMed Central · Cited by 71
Min, H., Jang, H.-J., Park, K. H., Hyun, S. Y., Park, S. J., Kim, J. H., Son, J., Kang, S. S., & Lee, H. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2041-z · Cited by 75
Kluckova, K., Sticha, M., Cerny, J., Mracek, T., Dong, L., Drahota, Z., Gottlieb, E., Neuzil, J., & Rohlena, J. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.110 · Cited by 66
“In sub-mitochondrial particles, it has been previously established that CII can produce ROS upon Qp site inhibition only when FAD is reduced and the dicarboxylate site is unoccupied.(7,38) In intact cells, this introduces an additional level of complexity, because the lack of enzymatically active CII will result in th…”
BackgroundMailloux, R. J. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102044 · Cited by 69
Hypoxia-induced ROS aggravate tumor progression through HIF-1α-SERPINE1 signaling in glioblastoma
Zhang, L., Cao, Y., Guo, X., Wang, X., Han, X., Kanwore, K., Hong, X., Zhou, H., & Gao, D. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200269 · Cited by 69
The impact of age-related dysregulation of the angiotensin system on mitochondrial redox balance
Vajapey, R. S., Rini, D. A., Walston, J. D., & Abadir, P. M. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00439 · Cited by 70
Zhu, H., Tamura, T., Fujisawa, A., Nishikawa, Y., Cheng, R., Takato, M., & Hamachi, I. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c02547 · Cited by 67
Park, S. ‐., Kwon, O. S., Andtbacka, R. H. I., Hyngstrom, J. R., Reese, V. R., Murphy, M. P., & Richardson, R. S. (2017) · Acta Physiologica · doi:10.1111/apha.12893 · Cited by 71
Radiation-Induced Alterations in Mitochondria of the Rat Heart
Sridharan, V., Aykin‐Burns, N., Tripathi, P., Krager, K. J., Sharma, S., Moros, E. G., Corry, P. M., Nowak, G., Hauer‐Jensen, M., & Boerma, M. (2014) · Radiation Research · doi:10.1667/rr13452.1 · Cited by 66
Hu, C., Zhao, L., Peng, C., & Li, L. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13835 · Cited by 64
Kim, Y., Baek, J., Kim, S. H., Kim, M.-A., Lee, B., Ryu, N., Kim, K., Choi, D.-G., Kim, H.-M., Murphy, M. P., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.11.013 · Cited by 64
Kôrge, P., John, S., Calmettes, G., & Weiss, J. N. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.768325 · Cited by 63
A paradoxical role of reactive oxygen species in cancer signaling pathway: Physiology and pathology
Ramalingam, V., & Rajaram, R. (2020) · Process Biochemistry · doi:10.1016/j.procbio.2020.09.032 · Cited by 61
Keshtzar, E., Khodayar, M. J., Javadipour, M., Ghaffari, M., Bolduc, D., & Rezaei, M. (2015) · Human & Experimental Toxicology · doi:10.1177/0960327115618247 · Cited by 61
Fuhrmann, D. C., Wittig, I., & Brüne, B. (2018) · Redox Biology · doi:10.1016/j.redox.2018.10.007 · Cited by 61
MDH2 produced OAA is a metabolic switch rewiring the fuelling of respiratory chain and TCA cycle
Molinié, T., Cougouilles, E., David, C., Cahoreau, E., Portais, J., & Mourier, A. (2022) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2022.148532 · Cited by 60
Степанова, А., Shurubor, Y. I., Valsecchi, F., Manfredi, G., & Galkin, A. S. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.06.002 · Cited by 58
Redox signaling in heart failure and therapeutic implications
Weissman, D., & Maack, C. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.013 · Cited by 60
Aerobic respiration: proof of concept for the oxygen-centric murburn perspective
Manoj, K. M., Parashar, A., Jacob, V. D., & Ramasamy, S. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1552896 · Cited by 62
Surprisingly long survival of premature conclusions about naked mole‐rat biology
Braude, S. H., Holtze, S., Begall, S., Brenmoehl, J., Burda, H., Dammann, P., del Marmol, D., Gorshkova, E. A., Henning, Y., Hoeflich, A., et al. (2020) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12660 · Cited by 57
Genetic, epigenetic and biochemical regulation of succinate dehydrogenase function
Moosavi, B., Zhu, X., Yang, W., & Yang, G. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0264 · Cited by 60
Respiratory complex II: ROS production and the kinetics of ubiquinone reduction
Grivennikova, V. G., Kozlovsky, V. S., & Vinogradov, A. D. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.10.008 · Cited by 54
Cobley, J. N. (2020) · Antioxidants · doi:10.3390/antiox9100933 · Cited by 57
Gómez-Gallardo, M., Pérez‐Gallardo, R. V., Sánchez, L. A., Díaz-Pérez, A. L., Cortés‐Rojo, C., Carmen, V. M., Saavedra‐Molina, A., Lara‐Romero, J., Jiménez‐Sandoval, S., Rodríguez, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111585 · Cited by 55
Redox control of non-shivering thermogenesis
Lettieri‐Barbato, D. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.04.002 · Cited by 52
Степанова, А., Konràd, C., Manfredi, G., Springett, R., Ten, V. S., & Galkin, A. S. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14654 · Cited by 52
Okuda, J., Niizuma, S., Shioi, T., Kato, T., Inuzuka, Y., Kawashima, T., Tamaki, Y., Kawamoto, A., Tanada, Y., Iwanaga, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072173 · Cited by 49
Shirakawa, R., Yokota, T., Nakajima, T., Takada, S., Yamane, M., Furihata, T., Maekawa, S., Nambu, H., Katayama, T., Fukushima, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51298-3 · Cited by 49
Is there a room for GABA in ROS and RNS signalling?
Bor, M., & Türkan, İ. (2019) · Environmental and Experimental Botany · doi:10.1016/j.envexpbot.2019.02.015 · Cited by 48
Oldford, C., Kuksal, N., Gill, R., Young, A., & Mailloux, R. J. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.02.012 · Cited by 46
Can, K., Menzfeld, C., Rinne, L., Rehling, P., Kügler, S., Golubiani, G., Dudek, J., & Müller, M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00479 · Cited by 47
Comparison of cytotoxicity of IQOS aerosols to smoke from Marlboro Red and 3R4F reference cigarettes
Davis, B. A., To, V., & Talbot, P. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.104652 · Cited by 44
Tardu, M., Bulut, S., & Kavaklı, İ. H. (2017) · Scientific Reports · doi:10.1038/srep40817 · Cited by 43
Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy
Compagnoni, G. M., Kleiner, G., Bordoni, A., Fortunato, F., Ronchi, D., Salani, S., Guida, M., Corti, C., Pichler, I., Bergamini, C., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.018 · Cited by 41
Lu, Z., & Imlay, J. A. (2017) · mBio · doi:10.1128/mbio.01873-16 · Cited by 40
Tang, Y., Wu, J., Sun, X., Tan, S., Li, W., Yin, S., Liu, L., Chen, Y., Liu, Y., Tan, Q., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114237 · Cited by 39
Lindsay, D. P., Camara, A. K. S., Stowe, D. F., Lubbe, R., & Aldakkak, M. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00058 · Cited by 38
Belosludtsev, K. N., Belosludtseva, N. V., Kosareva, E. A., Talanov, E. Y., Gudkov, S. V., & Dubinin, M. V. (2020) · Biochimie · doi:10.1016/j.biochi.2020.07.011 · Cited by 37
Manganese ions induce H2O2 generation at the ubiquinone binding site of mitochondrial complex II
Bonke, E., Zwicker, K., & Dröse, S. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.06.011 · Cited by 39
Self-citationMitoproteomics: Tackling Mitochondrial Dysfunction in Human Disease
Gómez‐Serrano, M., Camafeita, E., Loureiro, M., & Peral, B. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1435934 · Cited by 38
Colmenero, F. (2020) · Materials Advances · doi:10.1039/d0ma00019a · Cited by 36
Alqarni, A. M., Niwasabutra, K., Sahlan, M., Fearnley, H., Fearnley, J., Ferro, V. A., & Watson, D. G. (2019) · Metabolites · doi:10.3390/metabo9040075 · Cited by 35
Tomar, N., Zhang, X., Kandel, S. M., Sadri, S., Yang, C., Liang, M., Audi, S. H., Cowley, A. W., & Dash, R. K. (2021) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2021.148518 · Cited by 34
Wang, M., Li, G., Yang, Z., Wang, L., Zhang, L., Wang, T., Zhang, Y., Zhang, S., Han, Y., & Jia, L. (2016) · Oncotarget · doi:10.18632/oncotarget.14097 · Cited by 35
Effects of copper and temperature on heart mitochondrial hydrogen peroxide production
Isei, M. O., & Kamunde, C. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.006 · Cited by 35
Protective effects of chlorogenic acid in 3-nitropropionic acid induced toxicity and genotoxicity
Alarcón-Herrera, N., Flores-Maya, S., Bellido, B., García‐Bores, A. M., Mendoza, E., Ávila-Acevedo, J. G., & Hernández, E. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.04.048 · Cited by 32
Bonke, E., Siebels, I., Zwicker, K., & Dröse, S. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.07.026 · Cited by 30
Self-citationMitochondria-Mediated Anticancer Effects of Non-Thermal Atmospheric Plasma
Zhunussova, A., Vitol, E. A., Polyak, B., Tuleukhanov, S. T., Brooks, A. D., Sensenig, R., Friedman, G., & Orynbayeva, Z. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156818 · Cited by 32
Todt, C. E., Bailey, D. C., Pressley, A. S., Orfield, S. E., Denney, R. D., Snapp, I. B., Negga, R., Bailey, A. C., Montgomery, K. M., Traynor, W. L., et al. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.09.011 · Cited by 31
Why do cells need oxygen? Insights from mitochondrial composition and function
Manoj, K. M., Gideon, D. A., & Jaeken, L. (2021) · Cell Biology International · doi:10.1002/cbin.11746 · Cited by 28
Babu, D., Leclercq, G., Goossens, V., Berghe, T. V., Hamme, E. V., Vandenabeele, P., & Lefebvre, R. A. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.02.019 · Cited by 29
Taufani, I. P., Situmorang, J. H., Febriansah, R., Tasminatun, S., Sunarno, S., Yang, L., Chiang, Y., & Huang, C. (2023) · Human & Experimental Toxicology · doi:10.1177/09603271221149663 · Cited by 28
Rajab, B. S., Kassab, S., Stonall, C. D., Daghistani, H., Gibbons, S. M., Mamas, M. A., Smith, D., Mironov, A., Albalawi, Z., Zhang, Y. H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-04929-1 · Cited by 26
Molecular Bases of Brain Preconditioning
Deryagin, O., Gavrilova, S. A., Латыпович, Г. Х., Golubeva, A. V., Andrianov, V. V., Гульусовна, Я. Г., Валентинович, Б. С., & Кошелев, В. Б. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00427 · Cited by 27
Manoj, K. M., Bazhin, N. M., Tamagawa, H., Jaeken, L., & Parashar, A. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2060307 · Cited by 26
Zhang, G., Gao, S., Li, X., Zhang, L., Tan, H., Xu, L., Chen, Y., Geng, Y., Lin, Y., Aertker, B. M., et al. (2015) · Scientific Reports · doi:10.1038/srep09858 · Cited by 26
Detection of hydrogen peroxide production in the isolated rat lung using Amplex red
Audi, S. H., Friedly, N., Dash, R. K., Beyer, A., Clough, A. V., & Jacobs, E. R. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1511051 · Cited by 25
Anderson, R. F., Shinde, S. S., Hille, R., Rothery, R. A., Weiner, J. H., Rajagukguk, S., Maklashina, E., & Cecchini, G. (2014) · Biochemistry · doi:10.1021/bi401630m · Cited by 25
Respiratory complex II in mitochondrial dysfunction-mediated cytotoxicity: Insight from cadmium
Belyaeva, E. A. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.06.009 · Cited by 24
DNA‐PKcs and ATM modulate mitochondrial ADP‐ATP exchange as an oxidative stress checkpoint mechanism
Chen, W., Chiang, J., Shang, Z., Palchik, G. A., Newman, C., Zhang, Y., Davis, A. J., Lee, H., & Chen, B. P. C. (2023) · The EMBO Journal · doi:10.15252/embj.2022112094 · Cited by 22
Bianco, M., Lopes, J. A., Beiral, H. J. V., Filho, J. D. D., Frankenfeld, S. P., Fortunato, R. S., Gattass, C. R., Vieyra, A. R., & Takiya, C. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218986 · Cited by 22
Preventing Tumour Recurrence after Liver Transplantation: The Role of Machine Perfusion
BOTEON, Y. L., Carvalho, M. F., Panconesi, R., Muiesan, P., & Schlegel, A. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165791 · Cited by 22
Mitochondrial function is impaired in the primary visual cortex in an experimental glaucoma model
Arana, A. G. H., Vitar, R. M. L., Reides, C. G., Calabró, V., Marchini, T., Lerner, S. F., Evelson, P., & Ferreira, S. M. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108815 · Cited by 21
Trombetti, S., Sessa, R., Catapano, R., Rinaldi, L., Bianco, A. L., Feliciello, A., Izzo, P., & Grosso, M. (2021) · Antioxidants · doi:10.3390/antiox10101603 · Cited by 21
Roma, A., Tcheng, M., Ahmed, N., Walker, S., Jayanth, P., Minden, M. D., Hope, K. J., Rao, P. P. N., Luc, J., Doxey, A. C., et al. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-1032 · Cited by 23
Carvalho, M. F., BOTEON, Y. L., Guarrera, J. V., Modi, P. R., Lladó, L., Lurje, G., Kasahara, M., Dutkowski, P., & Schlegel, A. A. (2023) · Hepatology · doi:10.1097/hep.0000000000000394 · Cited by 21
Panconesi, R., Carvalho, M. F., Dondossola, D. E., Muiesan, P., Dutkowski, P., & Schlegel, A. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.855263 · Cited by 20
Fan, T. W. ‐., Daneshmandi, S., Cassel, T., Uddin, M. B., Sledziona, J., Thompson, P. T., Lin, P., Higashi, R. M., & Lane, A. N. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200178 · Cited by 20
Metadata
- Authors
- Dröse, S.
- Affiliations
- Goethe University Frankfurt (DE)
- Corresponding author
- Dröse, Stefan
- ORCID
- Dröse, Stefan
- Venue
- Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 1827
- Issue
- 5
- Pages
- 578-587
- ISSN
- 0005-2728 (ISSN-L)
- OpenAlex
- W2084933852
- Cited by
- 201
- References
- 158
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 14 · 2023: 16 · 2022: 23 · 2021: 19 · 2020: 21 · 2019: 13 · 2018: 23 · 2017: 14 · 2016: 14 · 2015: 14 · 2014: 12 · 2013: 3
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Bioenergetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SFB815)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- succinate dehydrogenase, succinate-ubiquinone oxidoreductase, mitochondrial reactive oxygen species, cardioprotection, preconditioning, postconditioning, ischemia-reperfusion injury, respiratory burst, TCA cycle, oxaloacetate, electron transport chain, cardiomyocytes
- MeSH terms
- Electron Transport, Humans, Mitochondria, Models, Biological, Succinates, Myocardial Reperfusion Injury, Reactive Oxygen Species, Ischemic Preconditioning, Myocardial, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review